COST-EFFECTIVENESS OF INTERVENTIONS AGAINST CHILDHOOD OBESITY

Author(s)

Ramos-Goñi JM, Valcárcel-Nazco C, Castilla-Rodríguez IServicio de Evaluación del Servicio Canario de Salud, Santa Cruz de Tenerife, Tenerife, Spain

OBJECTIVES: To estimate values for cost and effectiveness that assess the long-term efficiency of public health intervention to prevent and correct childhood obesity.  METHODS: A Markov model was developed that takes into account five diseases strongly associated with obesity: Diabetes Mellitus Type 2, Heart Disease, Breast Cancer, Colon Cancer and Stroke. Selection of disease was in base of high rates of morbidity and mortality. In the model, we considered 2 main states: normal weight (BMI < 30 kg/m2) and obese (BMI >= 30 kg/m2). From them, individuals can transit to states which representing the 5 diseases and death. Individuals can transit between normal weight and obese until they reach a certain age (30) when they can transit to the rest of states. The time horizon was 70 years. A literature review was performed in order to estimate parameters. The measure of effectiveness was QALYs and a discount of 3% was applied to costs and utilities. A 2-way probabilistic sensitivity analysis was made over 2 parameters which define the intervention: relative risk and cost of intervention. Also, a multivariate and probabilistic sensitivity analysis by 2nd order Monte Carlo (MC) simulations was performed for all parameters. Finally, acceptability curves and the expected value of perfect information were calculated. RESULTS: If the willingness to pay is € 30,000/QALY, any intervention that exceeds 1% prevention/correction, incurring in cost not exceeding € 2 per child and per year should be implemented, because the probability of hitting the decision is over 90% and does not incur on any opportunity cost. CONCLUSIONS: Long term efficient public health interventions, to prevent/correct childhood obesity, are low cost (not exceeding € 5 per child per year) due to the effectiveness of interventions, usually lower than 2% of prevention/correction over non-intervention.

Conference/Value in Health Info

2011-11, ISPOR Europe 2011, Madrid, Spain

Value in Health, Vol. 14, No. 7 (November 2011)

Code

PIH25

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Diabetes/Endocrine/Metabolic Disorders, Pediatrics

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×